Dermatology – Page 10

If Your Feet Show These 5 Signs, It Could Signal a Serious Health Issue!

By MedXY 08/03/2025

Persistent numbness, swelling, abnormal toenail changes, temperature irregularities, or slow-healing wounds in the feet may indicate underlying serious health problems. Early detection and medical consultation are crucial.

Allergy & Immunology Clinical Updates Dermatology Pediatrics Specialties

Prademagene Zamikeracel: A Breakthrough Gene Therapy for Chronic Wounds in Recessive Dystrophic Epidermolysis Bullosa (RDEB)

By MedXY 08/02/2025

A phase 3 trial demonstrates prademagene zamikeracel significantly accelerates healing and reduces pain in large, chronic RDEB wounds, offering a promising gene therapy with a favorable safety profile.

Clinical Updates Dermatology Infectious Diseases news Specialties

Dual IL-17A/F Blockade and Increased Candidiasis Risk

By MedXY 07/31/2025

Blocking both IL-17A and IL-17F impairs neutrophil migration, reducing antifungal defense and raising candidiasis risk in patients on bimekizumab, according to in vitro evidence.

Clinical Updates Dermatology news Specialties

Rapid Initial Benefits of Secukinumab in Early Psoriatic Arthritis: Insights from a Treat-to-Target Randomized Trial

By MedXY 07/31/2025

Early secukinumab use in newly diagnosed psoriatic arthritis delivers faster clinical improvement at 3 months compared to standard care, but this advantage diminishes by 6 months and beyond.

Clinical Updates Dermatology news Specialties

JAK Inhibitors and Venous Thromboembolism in Atopic Dermatitis: Clinical Risks and Practice Implications

By MedXY 07/30/2025

JAK inhibitors significantly increase the risk of venous thromboembolism compared to dupilumab and methotrexate in atopic dermatitis, underscoring the need for individualized risk stratification.

Clinical Updates Dermatology news Specialties

FDA Fast-Tracks Rezpegaldesleukin for Severe Alopecia Areata: Promise for a Challenging Disease

By MedXY 07/30/2025

The FDA has granted Fast Track status to rezpegaldesleukin (REZPEG), a novel biologic targeting regulatory T cells, for severe-to-very severe alopecia areata in patients aged ≥12 years. Phase 2b trial results are anticipated in December 2025.

Clinical Updates Dermatology Specialties

JAK Inhibitors and Thromboembolic Risk in Atopic Dermatitis: A Comparative Safety Signal

By MedXY 07/29/2025

A large real-world cohort study finds JAK inhibitors increase risk of venous thromboembolism versus dupilumab and methotrexate in atopic dermatitis, highlighting the need for individualized therapy.

Dermatology news

Scrotal Eczema: Understanding, Treating, and Preventing This Common Yet Distressing Condition

By MedXY 07/26/2025

Scrotal eczema causes significant discomfort but can be effectively managed with the right care. Learn about causes, treatments, and tips to prevent flare-ups.

Dermatology news Plastic Surgery

Hair Transplantation: Is It a Permanent Solution for Hair Loss?

By MedXY 07/26/2025

Exploring whether hair transplantation truly offers a permanent fix for hair loss, this article examines scientific evidence, common myths, and practical advice for those considering the procedure.

Dermatology news

Can Hair Transplants Offer a Permanent Solution to Balding?

By MedXY 07/26/2025

Explore whether hair transplants provide a lasting solution to baldness, along with insights into prevention and treatment options.